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Local anesthetics (LAs) are drugs that inhibit membrane depolarization by reducing sodium conductance. In addi-
tion to the most prominent and well-defined function of LAs described above, numerous studies have shown that LAs 
possess many other properties, such as anti-inflammatory, anti-arrhythmic or analgesic activities. Furthermore, LAs 
are structurally similar to histamine H-receptor antagonists. Thus, LAs can be considered antihistaminic drugs. The 
aim of the present study was to determine and compare the antihistaminic effects of lidocaine derivatives - JCB-1, 
JCB-2 and JCB-3 - on the isolated guinea pig ileum. Only JCB-1 and JCB-2 at the highest concentration (10-4M) 
showed the antihistaminic effect. The studied compounds showed a dose-dependent effect. Interestingly, lower con-
centrations of the studied compounds (10-8M and 10-10M) caused the opposite effect – increased the contraction of 
the ileum induced by histamine. These effects necessitate further studies. Nevertheless, this is the first time that 
JCB compounds have been demonstrated to possess antihistaminic properties.
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INTRODUCTION
Local anaesthetic agents (LAs) can be defined as 
drugs which are used to produce reversible in-
terruption of pain impulses in a specific region of 
the body by direct interaction with voltage-gated 
Na channels, without loss of consciousness in pa-
tients. Most of the LAs consist of an aromatic ring 
linked by a carbonyl containing moiety through 
a carbon chain to a substituted amino group. As 
mentioned previously, LAs cause reversible inter-
ruption of the conduction of impulses in periphe-
ral nerves. The primary electrophysiological effect 
of these drugs is a local decrease in the rate and 
degree of depolarisation of the nerve membrane, 
so the threshold potential for transmission is not 
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reached and the electrical impulse is not propaga-
ted down the nerve. This effect is due to blockade 
of sodium channels, thereby impairing sodium ion 
flux across the membrane. In addition to the most 
prominent and well-defined function of LAs de-
scribed above, numerous studies have shown that 
LAs possess many other properties, such as anti-
inflammatory, anti-arrhythmic, analgesic, anti-
convulsant, antifungal and antibacterial activities 
(aydin et al., 2001; caSutto et al., 2006; de iuLis et 
al., 2001; Frey, 2001; Goodman et al., 2002; hel-
LsTröm et al., 1988; hollMann and durieux, 2000; 
Pina-Vaz et al., 2000).
The structure of LAs resembles the structure 
of histamine H-receptor antagonists, suggesting 
that LAs may influence histamine release. Seve-
ral studies have shown that lidocaine (LID) used 
at a concentration lower than that used in infil-
tration anesthesia inhibits histamine release from 
mast cells (KaziMierczaK et al., 1976). Moreover, 
some studies had shown that low concentrations 
of LID or mepivacaine inhibited histamine relea-
se from activated mast cells. The effect was more 
intense when pH was more alkaline (suzuki et al., 
2000). Recent studies suggest that both inhaled 
and intravenous LID inhibit bronchial contraction 
caused by histamine (Groben et al., 2007). On the 
other hand, a few studies have demonstrated that 
LID may cause bronchial contraction induced by 
histamine (hirota et al., 1999). 
Even though there are many available LAs, 
their activity time is not satisfactorily long and 
they often produce untoward side effects. Hence, 
the search for a long-lasting, safer LA is the goal 
of many research studies. The aim of the present 
study was to determine and compare the antihi-
staminic effects of LID derivatives - JCB-1, JCB-2 
and JCB-3 - on the isolated guinea pig ileum. LID 
was used as the reference drug.
MATERIALS AND METHODS
Animals
Male and female guinea pigs (300–450 g) were used 
in the experiment. The animals were housed and 
fed in a laboratory maintained at constant tempe-
rature of 22°C under standard conditions (12:12 
h light-dark cycle, standard pellet diet, water ad 
libitum). The treatment of laboratory animals in 
the present study was in accordance with the re-
spective Polish and European regulations and was 
approved by the Local Ethics Committee.
Drugs
JCB-1, JCB-2 and JCB-3, LID (lignocainum hydro-
chloricum, Polfa, Poland) were dissolved in distil-
led water.
Isolated guinea pig ileum
Male and female guinea pigs were sacrificed by cer-
vical dislocation. The ileum was immediately remo-
ved and cut into approximately 2.5-cm segments. 
The segments were placed in a carbogen-aerated 
organ bath (37oC) containing buffer (120 µM NaCl, 
5.6 µM KCl, 2.2 M MgCl, 2.4 M CaCl, 19 µM NaHCO3 
and 10 µM glucose). One end of the ileal segment 
was attached to the transducer (FDT10-A), and the 
resting tension was adjusted to a load of 0.5 g. All 
the samples were allowed to equilibrate for at least 
30 min before contractions were measured. After 
30-minute incubation, 10-7 M histamine was ad-
ded to the buffer and the contraction of the ileum 
was recorded. Next, the ileum was washed twice 
with buffer and the compound under investigation 
was added to the buffer for 15 min. Finally, another 
concentration of 10-7M histamine was added and 
the change in ileum contraction strength was re-
corded. The contractions were recorded using com-
puter software (MP35 Data Acquisition Unit).
Statistical analysis
The data are expressed as mean ± SEM. Differen-
ces between treatments and controls were exami-
ned for statistical significance using a paired t-
test, where the p-value of less than 0.05 indicated 
a statistically significant difference.
RESULTS
JCB-1 used at 10-6M, 10-8M and 10-10M concentra-
tions increased the strength of ileum contraction 
by 7.36%, 23.67% and 45.67%, respectively. In 
contrast, at a concentration of 10-4M the strength 
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of ileum contraction was significantly decreased 
by 18.16%.
Similarly, JCB-2 at concentrations of 10-6M, 
10-8M and 10-10M increased the strength of ileum 
contraction by 33.9%, 23.64% and 17.09%, re-
spectively. However, when used at a concentration 
of 10-4M, it significantly decreased the strength 
of ileum contraction by 26.08%. The compound 
JCB-3 significantly increased the histamine-indu-
ced contractions of the guinea pig ileum at con-
centrations of 10-8M and 10-10M by 19.18% and 
10.33%, respectively.
LID at concentrations of 10-6M, 10-8M and 
10-10M increased the strength of ileum contrac-
tions induced by histamine by 6.66%, 13.47% and 
8.55%, respectively. No statistically significant 
effect was observed at a concentration of 10-4M.
DISCUSSION
The guinea pig ileum is a very common model used 
to determine whether a potential drug has an anti- 
histaminic effect or not (Larsson et al., 2007). As 
mentioned previously, the structure of LAs resem-
bles the structure of histamine H1-receptor anta-
gonists. As the studied compounds are LID deri-
vatives, we attempted to determine their effect on 
H1 receptor. Recent data indicate that LAs, except 
of their local-anaesthetic action, can also have an-
tihistaminic properties (KaziMierczaK et al., 1976; 
Librowski, 2005). It has also been proved that an-
tihistaminic agents exhibit analgesic and anti-in-
flammatory activities (Panaszek et al., 2007; Tamad-
donFard et al., 2008). Furthermore, studies in the 
guinea pig ileum demonstrate that LAs behave si-
milarly to histamine H1-receptor antagonists (ho-
rio et al., 1997; Librowski et al., 2009). The studied 
compounds showed a dose-dependent effect. Only 
JCB-1 and JCB-2 at the highest concentration (10-
4M) showed antihistaminic effect. The effect was 
much more intense than the effect caused by LID 
at the same concentration. Considering all the stu-
died compounds, JCB-2 was characterized by the 
greatest strength; it inhibited ileum contractions 
induced by histamine at a concentration of 10-4M 
by 26%. Interestingly, lower concentrations of the 
studied compounds (10-8M and 10-10M) caused the 
opposite effect. They increased the contractions of 
the guinea pig ileum induced by histamine. JCB-1 






















Fig. 1. The effect of JCB-1 and lidocaine on histamine-in-
duced contraction in the guinea pig ileum. The results are 
expressed as mean ± SEM of 8 samples per group. * p < 0.05, 























Fig. 2. The effect of JCB-2 and lidocaine on histamine-in-
duced contraction in the guinea pig ileum. The results are 
expressed as mean ± SEM of 8 samples per group. * p < 0.05, 




















Fig. 3. The effect of JCB-3 and lidocaine on histamine-in-
duced contraction in the guinea pig ileum. The results are 
expressed as mean ± SEM of 8 samples per group. * p < 0.05, 
** p < 0.01, *** p < 0.001
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10-10M it increased the ileum contraction by 45%. 
Moreover, the lower the concentration of JCB-1 
was, the stronger the effect was observed. Both 
the increases and the decreases in ileum contrac-
tions were much greater for the studied compoun-
ds than for LID.
Recent data indicate that LID can either en-
hance (hirota et al., 1999; hirota et al., 2001) or 
decrease the strength of bronchi or trachea con-
traction induced by histamine (downes and loeh-
ninG, 1977; Groeben and PeTers, 2007). Our results 
are in agreement with these findings. Perhaps the 
fact that JCB-1, JCB-2 and JCB-3 are derivatives 
of LID is associated with their differential influen-
ce on contractions of the guinea pig ileum induced 
by histamine.
The mechanism by which JCBs exert their 
antihistaminic effects remains unknown. This 
issue, in addition to the observations that lower 
concentrations exert opposite effects, necessitates 
further studies. Nevertheless, this is the first time 
that JCB compounds have been demonstrated to 
possess antihistaminic properties.
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